Health
+1

Jul 23, 2026
•
3 min read
Novo Nordisk sues Eli Lilly for false advertising and making misleading claims about popular weight loss drugs.

Health
+1

Jul 17, 2026
•
2 min read
The FDA approved the first cholesterol pill of its kind, offering high-risk patients a new alternative to injectable medications.

Health
+1

Jun 29, 2026
•
4 min read
Department of Justice announces $6.5 billion health care fraud case involving four hundred and fifty-five defendants.

Health
+1

Jun 29, 2026
•
4 min read
States are taking on powerful prescription drug middlemen, setting up a legal fight that could reshape pharmacy access and medication costs nationwide.

Health
+1

Jun 25, 2026
•
3 min read
With Ebola cases surpassing 1,000, the Trump administration is seeking $1.4 billion to contain the outbreak abroad.

Health
+1

Jun 24, 2026
•
3 min read
Ebola outbreak in Congo and Uganda continues to intensify as efforts to contain the spread have been increased.

Health
+1

Jun 9, 2026
•
2 min read
A flesh-eating parasite once eradicated from America has returned to Texas, triggering emergency measures and raising industry concerns.

Medicine
+1

May 13, 2026
•
2 min read
Novo Nordisk posts stronger than expected quarterly earnings report fueled by sales of Wegovy.

Medicine
+2

Apr 30, 2026
•
2 min read
New York doctor become first surgeon to perform cataract surgery using Apple’s Vision Pro headset.

Health
+1

Apr 3, 2026
•
5 min read
U.S. Food and Drug Administration approves pill form of Eli Lilly’s GLP-1 weight loss drug.

Medicine
+1

Mar 19, 2026
•
5 min read
The patent for semaglutide in India expires Friday and will likely trigger a new wave of generic versions on the market.


A lightning-fast read, packed with essentials, shortlists make it easy to stay informed, savvy and ready for your day.